(Q51905748)

17 April 2018

meta-analysis

0 references

title

Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis (English)

1 reference

17 April 2018

1 reference

1 reference

Govinda J Weerakkody

1

1 reference

17 April 2018

Joseph A Jakubowski

2

1 reference

17 April 2018

John T Brandt

3

1 reference

17 April 2018

Christopher D Payne

4

1 reference

17 April 2018

Hideo Naganuma

5

1 reference

17 April 2018

Kenneth J Winters

6

1 reference

17 April 2018

publication date

1 September 2007

1 reference

17 April 2018

Journal of Cardiovascular Pharmacology and Therapeutics

published in

1 reference

17 April 2018

volume

12

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

205-212

1 reference

17 April 2018

Biology and pharmacology of the platelet P2Y12 receptor

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Loading, pretreatment, and interindividual variability issues with clopidogrel dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Drug insight: Clopidogrel nonresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248407304731

21 January 2018

Identifiers

DOI

10.1177/1074248407304731

1 reference

17 April 2018

1 reference

17 April 2018